{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:15:41Z","timestamp":1788423341087,"version":"build-2803163510"},"reference-count":26,"publisher":"American Chemical Society (ACS)","issue":"6","license":[{"start":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T00:00:00Z","timestamp":1491264000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P41GM103393"],"award-info":[{"award-number":["P41GM103393"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI 084004"],"award-info":[{"award-number":["R01AI 084004"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI 097177"],"award-info":[{"award-number":["R01AI 097177"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006151","name":"Basic Energy Sciences","doi-asserted-by":"publisher","award":["DE-AC02-76SF00515"],"award-info":[{"award-number":["DE-AC02-76SF00515"]}],"id":[{"id":"10.13039\/100006151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fluorination is a well-known strategy for improving the bioavailability of drug molecules. However, its impact on efficacy is not easily predicted. On the basis of inhibitor-bound protein crystal structures, we found a beneficial fluorination spot for inhibitors targeting methionyl-tRNA synthetase of Trypanosoma brucei. In particular, incorporating 5-fluoroimidazo[4,5-b]pyridine into inhibitors leads to central nervous system bioavailability and maintained or even improved efficacy.<\/jats:p>","DOI":"10.1021\/acsinfecdis.6b00036","type":"journal-article","created":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T12:57:13Z","timestamp":1459774633000},"page":"399-404","source":"Crossref","is-referenced-by-count":31,"title":["5-Fluoroimidazo[4,5-\n                    <i>b<\/i>\n                    ]pyridine Is a Privileged Fragment That Conveys Bioavailability to\nPotent Trypanosomal Methionyl-tRNA Synthetase Inhibitors"],"prefix":"10.1021","volume":"2","author":[{"given":"Zhongsheng","family":"Zhang","sequence":"first","affiliation":[{"name":"University of Washington , , 1705 N.E. Pacific Street , , ,","place":["Seattle, Washington, United States, 98195"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho Yeow","family":"Koh","sequence":"additional","affiliation":[{"name":"University of Washington , , 1705 N.E. Pacific Street , , ,","place":["Seattle, Washington, United States, 98195"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranae M.","family":"Ranade","sequence":"additional","affiliation":[{"name":"University of Washington , , 750 Republican Street , , ,","place":["Seattle, Washington, United States, 98109"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Shibata","sequence":"additional","affiliation":[{"name":"University of Washington , , 1705 N.E. Pacific Street , , ,","place":["Seattle, Washington, United States, 98195"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Robert","family":"Gillespie","sequence":"additional","affiliation":[{"name":"University of Washington , , 750 Republican Street , , ,","place":["Seattle, Washington, United States, 98109"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Hulverson","sequence":"additional","affiliation":[{"name":"University of Washington , , 750 Republican Street , , ,","place":["Seattle, Washington, United States, 98109"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Huang","sequence":"additional","affiliation":[{"name":"University of Washington , , 1705 N.E. Pacific Street , , ,","place":["Seattle, Washington, United States, 98195"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Nguyen","sequence":"additional","affiliation":[{"name":"University of Washington , , 1705 N.E. Pacific Street , , ,","place":["Seattle, Washington, United States, 98195"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagendar","family":"Pendem","sequence":"additional","affiliation":[{"name":"University of Washington , Bagley Hall, , , ,","place":["Seattle, Washington, United States, 98195"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Gelb","sequence":"additional","affiliation":[{"name":"University of Washington , Bagley Hall, , , ,","place":["Seattle, Washington, United States, 98195"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe L. M. J.","family":"Verlinde","sequence":"additional","affiliation":[{"name":"University of Washington , , 1705 N.E. Pacific Street , , ,","place":["Seattle, Washington, United States, 98195"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim G. J.","family":"Hol","sequence":"additional","affiliation":[{"name":"University of Washington , , 1705 N.E. Pacific Street , , ,","place":["Seattle, Washington, United States, 98195"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick S.","family":"Buckner","sequence":"additional","affiliation":[{"name":"University of Washington , , 750 Republican Street , , ,","place":["Seattle, Washington, United States, 98109"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkang","family":"Fan","sequence":"additional","affiliation":[{"name":"University of Washington , , 1705 N.E. Pacific Street , , ,","place":["Seattle, Washington, United States, 98195"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2016,4,4]]},"reference":[{"key":"2026090303542641900_cit1","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Current concepts \u2013\ncontrol of neglected tropical diseases","volume":"357","author":"Hotez","year":"2007","journal-title":"N. Engl.\nJ. Med."},{"key":"2026090303542641900_cit2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"Lancet"},{"key":"2026090303542641900_cit3","unstructured":"Trypanosomiasis,\nhuman African (sleeping sickness), http:\/\/www.who.int\/mediacentre\/factsheets\/fs259\/en\/."},{"key":"2026090303542641900_cit4","unstructured":"Mapping the risk of human African trypanosomiasis, http:\/\/www.who.int\/trypanosomiasis_african\/country\/risk_AFRO\/en\/."},{"key":"2026090303542641900_cit5","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1128\/AAC.01796-10","article-title":"Selective inhibitors of methionyl-tRNA synthetase have\npotent activity against Trypanosoma brucei infection\nin mice","volume":"55","author":"Shibata","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026090303542641900_cit6","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.1021\/jm300303e","article-title":"Urea-based inhibitors of Trypanosoma brucei methionyl-tRNA\nsynthetase: selectivity and in vivo characterization","volume":"55","author":"Shibata","year":"2012","journal-title":"J. Med. Chem."},{"key":"2026090303542641900_cit7","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1021\/jm025502x","article-title":"Nanomolar inhibitors of Staphylococcus aureus methionyl\ntRNA synthetase with potent antibacterial activity against gram-positive\npathogens","volume":"45","author":"Jarvest","year":"2002","journal-title":"J. Med. Chem."},{"key":"2026090303542641900_cit8","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1016\/j.bmcl.2004.05.070","article-title":"Definition of the heterocyclic pharmacophore of bacterial\nmethionyl tRNA synthetase inhibitors: potent antibacterially active\nnon-quinolone analogues","volume":"14","author":"Jarvest","year":"2004","journal-title":"Bioorg. Med. Chem.\nLett."},{"key":"2026090303542641900_cit9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1039\/B610213C","article-title":"Fluorine in\nmedicinal chemistry","volume":"37","author":"Purser","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"2026090303542641900_cit10","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1021\/cr4002879","article-title":"Fluorine in pharmaceutical\nindustry: fluorine-containing drugs introduced to the market in the\nlast decade (2001\u20132011)","volume":"114","author":"Wang","year":"2014","journal-title":"Chem. Rev."},{"key":"2026090303542641900_cit11","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.drudis.2013.03.003","article-title":"Matched\nmolecular pair analysis in drug discovery","volume":"18","author":"Dossetter","year":"2013","journal-title":"Drug\nDiscovery Today"},{"key":"2026090303542641900_cit12","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1021\/jm500022q","article-title":"Using matched\nmolecular series as a predictive tool to optimize biological activity","volume":"57","author":"O\u2019Boyle","year":"2014","journal-title":"J. Med. Chem."},{"key":"2026090303542641900_cit13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1021\/jm201441k","article-title":"Fragment based drug discovery: practical implementation based on 19F NMR spectroscopy","volume":"55","author":"Jordan","year":"2012","journal-title":"J. Med. Chem."},{"key":"2026090303542641900_cit14","doi-asserted-by":"publisher","first-page":"12949","DOI":"10.1021\/ja905207t","article-title":"Design and NMR-based screening of\nLEF, a library of chemical fragments with different local environment\nof fluorine","volume":"131","author":"Vulpetti","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"2026090303542641900_cit15","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.str.2012.07.011","article-title":"Distinct\nstates of methionyl-tRNA synthetase indicate inhibitor binding by\nconformational selection","volume":"20","author":"Koh","year":"2012","journal-title":"Structure"},{"key":"2026090303542641900_cit16","doi-asserted-by":"publisher","first-page":"e2775","DOI":"10.1371\/journal.pntd.0002775","article-title":"Structures\nof Trypanosoma brucei methionyl-tRNA synthetase with\nurea-based inhibitors provide guidance for drug design against sleeping\nsickness","volume":"8","author":"Koh","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"2026090303542641900_cit17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3762\/bjoc.10.4","article-title":"The difluoromethylene (CF2) group in aliphatic chains: synthesis and conformational preference\nof palmitic acids and nonadecane containing CF2 groups","volume":"10","author":"Wang","year":"2014","journal-title":"Beilstein J. Org. Chem."},{"key":"2026090303542641900_cit18","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1021\/jo402690j","article-title":"A 6\u2032-fluoro-substituent in bicyclo-DNA increases\naffinity to complementary RNA presumably by CF\u2013HC pseudohydrogen\nbonds","volume":"79","author":"Dugovic","year":"2014","journal-title":"J. Org. Chem."},{"key":"2026090303542641900_cit19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/chem.19970030115","article-title":"Organic fluorine hardly\never accepts hydrogen bonds","volume":"3","author":"Dunitz","year":"1997","journal-title":"Chem.\u2013Eur.\nJ."},{"key":"2026090303542641900_cit20","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1021\/ci9002393","article-title":"Fluorine bonding \u2013 how does it work in protein-ligand\ninteractions?","volume":"49","author":"Zhou","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"2026090303542641900_cit21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/1087057114548832","article-title":"Identification of potent\ninhibitors of the Trypanosoma brucei methionyl-tRNA\nsynthetase via high-throughput orthogonal screening","volume":"20","author":"Pedro\u0301-Rosa","year":"2015","journal-title":"J. Biomol. Screening"},{"key":"2026090303542641900_cit22","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.1128\/AAC.01573-15","article-title":"Inhibitors of methionyl-tRNA synthetase have potent\nactivity against Giardia intestinalis trophozoites","volume":"59","author":"Ranade","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026090303542641900_cit23","doi-asserted-by":"publisher","first-page":"e1151","DOI":"10.1371\/journal.pntd.0001151","article-title":"SCYX-7158,\nan orally-active benzoxaborole for the treatment of stage 2 human\nAfrican trypanosomiasis","volume":"5","author":"Jacobs","year":"2011","journal-title":"PLoS Neglected Trop.\nDis."},{"key":"2026090303542641900_cit24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1017\/S0031182000062284","article-title":"The relationship\nbetween duration of infection with Trypanosoma brucei in mice and the efficacy of chemotherapy","volume":"75","author":"Jennings","year":"1977","journal-title":"Parasitology"},{"key":"2026090303542641900_cit25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4269\/ajtmh.1987.36.46","article-title":"Effects of\nthe ornithine decarboxylase inhibitors dl-\u03b1-difluoromethylornithine\nand \u03b1-monofluoromethyldehydroornithine methyl ester alone and\nin combination with suramin against Trypanosoma brucei brucei central nervous system models","volume":"36","author":"Bacchi","year":"1987","journal-title":"Am. J. Trop.\nMed. Hyg."},{"key":"2026090303542641900_cit26","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1128\/AAC.00246-11","article-title":"Antitrypanosomal activity\nof fexinidazole, a new oral nitroimidazole drug candidate for treatment\nof sleeping sickness","volume":"55","author":"Kaiser","year":"2011","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["ACS Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsinfecdis.6b00036","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/2\/6\/399\/67182802\/acsinfecdis.6b00036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/2\/6\/399\/67182802\/acsinfecdis.6b00036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:54:35Z","timestamp":1788422075000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article\/2\/6\/399\/788334\/5-Fluoroimidazo-4-5-b-pyridine-Is-a-Privileged"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,4]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,4,4]]},"published-print":{"date-parts":[[2016,6,10]]}},"URL":"https:\/\/doi.org\/10.1021\/acsinfecdis.6b00036","relation":{},"ISSN":["2373-8227"],"issn-type":[{"value":"2373-8227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,4]]}}}